CTLA4 and neoplasm: Glycolysis is essential for effector T cell function; therefore, upregulation of PD-1 and CTLA-4 could be detrimental to anti-tumour immunity and may reflect the skewing of T cells toward an altered phenotype facilitated by PD-1 and CTLA-4 metabolic reprogramming.